miR-25-3p targets FASL and PTEN to reduce protein levels, inhibit EZH2 and H3K27me3, de-repress eNOS and SOCS3 genes, thereby alleviating MI and providing heart protection. This evidence concerns the gene EZH2 and myocardial infarction.